Thursday, February 21, 2019

The 3 Best Dividend Stocks to Buy Now

This site uses Akismet to reduce spam. Learn how your comment data is processed.

As we approach the end of the business cycle, investors are looking for the best dividend stocks to buy now to add some extra income to their portfolios.

Even if the stock market is volatile, a dividend-paying stock can keep money flowing into your portfolio. And to help you find them, we're bringing you three of the best dividend stocks to add to your portfolio right now.

These income stocks are also real estate investment trusts (REITs). This is important because REITs have produced gains that have outpaced the broader market for over 35 years.

This class of investment has generated 11.61% in annualized returns since 1980. Over that same period, the S&P 500 has produced just 8.39% in annualized returns on average. That helps provide an added cushion if the market drops.

Here are three of the best dividend stocks to buy today…

Best Dividend Stocks to Buy Now, No. 3: Apartment Investment and Management Co.

Interest rates have gone up close to a full percentage point in the past year. That was one of the reasons the stock market closed the year in the red.

But higher interest rates aren't all bad news. Higher interest rates have created positive momentum for rent-based REITs.

Powerful Investment Income Stream: The Treasury is sitting on an $11.1 billion money pool. By adding your name to a special distribution list, you could begin collecting $1,795 or more every month. Get the details…

When interest rates soar, mortgages become more expensive. This means that it's going to cost more to buy and own a home, which drives people to choose to rent rather than buy.

These choices are a catalyst for higher rents and more revenue for rent-based property management firms.

Apartment Investment and Management Co. (NYSE: AIV) is one of the largest REITs that deals with apartments, covering 17 U.S. states and 130 communities.

Because it's geographically diversified, AVI has a portfolio that can shield the company from shifting property values and rental rates in different parts of the country.

In addition to any share price gains investors will receive, AIV also offers investors a 3% dividend yield.

This 3% yield is nearly double the S&P 500 average.

Plus, AIV has a perfect Money Morning VQScore™ of 4, which means that this stock could break out higher soon.

Best Dividend Stocks to Buy Now, No. 2: Sunstone Hotel Investors Inc.

Volatile markets can be the perfect breeding ground for some market-beating gains. You just need to know where to put your investment.

Even with uncertainty in the market, the United States has strong job growth and some of the lowest unemployment levels in four decades. Because of this, consumer confidence is up, and consumers are spending more.

Travel happens to be one of the primary things that Americans like to indulge in when there is cash available. In fact, the nation saw the busiest holiday season in 2018 since 2004.

This means that another profitable dividend stock and REIT is going to be Sunstone Hotel Investors Inc. (NYSE: SHO).

This is a mid-cap REIT investment with 22 major hotels and over 10,000 rooms under its umbrella. Some of the recognizable names include Hyatt, Hilton, and Marriott.

Travel spending is predicted to remain strong this year since the labor market isn't showing signs of contracting. This will ensure that SHO delivers substantial returns to investors.

On top of those gains, this REIT also has a 4.8% dividend yield.

That's extra income right into your portfolio.

But our best dividend stock is even better…

The Best Dividend Stocks to Buy Now

Join the conversation. Click here to jump to comments…

Wednesday, February 20, 2019

U.S.-China Trade War Boosts Fast-Growing Southeast Asia

&l;p&g;Trade tensions between the U.S. and China are adding rocket fuel to the liftoff of Southeast Asia&s;s economies. American tariffs on Chinese-made goods have sped the shift of contract manufacturing to&a;nbsp;ASEAN (Association of Southeast Asian Nations&l;span&g;)&l;/span&g;&a;nbsp;countries, such as Vietnam and Thailand. The increase in foreign direct investment into the 10-nation regional trading bloc has been underway for a number of years, however, the trade war continues to drive even more capital into the region. Nikkei just published an article this month titled:&l;span&g;&a;nbsp;&l;/span&g;&l;a href=&q;https://asia.nikkei.com/Economy/Southeast-Asia-bucks-trend-of-sinking-global-foreign-investment&q; target=&q;_blank&q;&g;&a;ldquo;Southeast Asia bucks trend of sinking global foreign investment&a;rdquo;&l;/a&g;.

Our Singapore-based venture capital firm is tracking these trends closely. They look like a replay of previous events in China itself, where export manufacturing and FDI helped to create both wider prosperity and a hothouse environment for high-growth tech startups. Now the torch is being passed to Southeast Asia&a;mdash;fanned higher by the trade war.&l;span&g;&a;nbsp;&l;/span&g;&l;a href=&q;https://www.economist.com/briefing/2019/01/24/globalisation-has-faltered&q; target=&q;_blank&q;&g;A recent article in The Economist&l;/a&g;, highlights that &a;ldquo; trade tensions are boosting activity in South-East Asia.&a;rdquo;

&l;img class=&q;dam-image bloomberg size-large wp-image-43209509&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/43209509/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Nguyen Xuan Phuc, Vietnam&s;s prime minister, listens to an interviewer&s;s question during a Bloomberg Television interview in Hanoi on January 18, 2019. A red-hot economy, business-friendly policies and a Communist party led by free-traders: that&s;s the elevator pitch Phuc is delivering to global investors amid the U.S.-China trade war. (Photo: Maika Elan/Bloomberg)

&a;ldquo;We are ready to grab the opportunity,&a;rdquo; Vietnam&a;rsquo;s Prime Minister Nguyen Xuan Phuc told Bloomberg in January. His country has a head start. Vietnam began making athletic shoes and sportswear for Adidas, Nike and other firms in the 1990s. Samsung now makes most of its mobile phones in Vietnam&a;mdash;amazingly, the nation has become the chief source for the world&a;rsquo;s largest phone producer, while the company is Vietnam&a;rsquo;s largest employer. And last fall the Chinese acoustics manufacturer Goertek announced that its production of Apple&a;rsquo;s Airpods wireless headphones will move to Vietnam, because of the trade war.

Thailand has growing clusters of vehicle assembly plants for Japanese, U.S., and Chinese auto companies, while also making components for tier 1 suppliers. Panasonic is joining the latter by shifting production of auto stereos from China. Meanwhile, the Thai electronics maker SVI has been sifting through requests from firms which, until now, had their work done in China. &a;ldquo;The trade war is good for us,&a;rdquo; SVI&a;rsquo;s&a;nbsp;&l;span&g;chief executive,&a;nbsp;&l;/span&g;&l;span&g;Pongsak Lothongkam,&l;/span&g; said to&l;span&g;&a;nbsp;&l;/span&g;&l;em&g;Business Insider&l;/em&g;. &q;We have been approached by so many companies that we have to prioritize.&q;

Not all of the movement from China to Southeast Asia is in high-tech or high-value goods. Cambodia snared bicycle production for U.S.-based Kent International, whose budget-priced bikes are sold in big-box retail outlets and online. Other light manufacturing for export, such as in apparel and furniture, is picking up across ASEAN countries while Chinese volume tails off.

But the shift is on. In 2012, Japanese firms had more direct investment and more personnel on the ground in China than in ASEAN, but the picture has flipped rapidly. Numbers from 2017 showed Japan investing $22 billion in ASEAN versus just $9.6 billion in China, while Japan&a;rsquo;s Foreign Ministry reported that roughly 83,000 expats are working in ASEAN, surpassing the 70,000 in China.

Further, it seems the U.S.-China trade war&a;mdash;mixed with uncertainty over the countries&a;rsquo; future trade relations&a;mdash;has affected key players&a;rsquo; outlooks as well as results. Late last summer, a survey of U.S. firms manufacturing in China found that 18.5% had either moved production to Southeast Asia or were considering it. Early this year, when attendees at the Asian Financial Forum in Hong Kong were surveyed on where they felt good investment returns in 2019 were most likely,&l;span&g;39% said Southeast Asia, 35% indicated China and 16% opted for the U.S.&l;/span&g;

Labor costs have been a fundamental driver of shifting manufacturing to Southeast Asia. ASEAN wages can run as low as one-third to one-half those in China. But t&l;span&g;his isn&a;rsquo;t the only factor. P&l;/span&g;roduction in the majority of industries is incorporating new technology and smart automation. If you need to upgrade, why not start fresh in a new location instead of trying to retrofit? Here again, Southeast Asia beckons.

I launched my VC firm in Singapore seven years ago when my partners and I saw huge opportunities for startup activity across the region. Now the manufacturing shift promises to take that activity to new levels. As we witnessed in China, the growth in the manufacturing economy contributed to&l;span&g;&a;nbsp;&l;/span&g;&l;a href=&q;https://www.mckinsey.com/business-functions/operations/our-insights/the-future-of-manufacturing&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;87% of private sector R&a;amp;D&l;/a&g;&l;span&g;&a;nbsp;&l;/span&g;in the early years, not only promoting innovation and productivity in the country but subsequently creating a budding technology sector for future growth. This manufacturing shift towards the ASEAN region will mean more Southeast Asians working with and learning about advanced technology and more prosperous societies creating in-country consumer demand.

Which countries are poised for the greatest takeoff? Many observers favor Vietnam, which already exports vigorously ($94 billion in electrical and electronics goods alone in 2017), offers a large workforce (population over 95 million, skewed young), and has worked to build good trade relations globally. But all ASEAN nations stand to gain from increased export manufacturing. Japan&a;rsquo;s Nomura Group sees significant upside for Malaysia, Thailand, The Philippines, Indonesia, Singapore, and Cambodia along with Vietnam.

&l;img class=&q;size-full wp-image-264&q; src=&q;http://blogs-images.forbes.com/vinnielauria/files/2019/02/Graph.jpg?width=960&q; alt=&q;&q; data-height=&q;465&q; data-width=&q;900&q;&g; Countries affected by the U.S.-China trade war (Source: Nomura Group)

Certainly, challenges still loom. Tech skills will need to improve in many ASEAN locales, including places like Vietnam and Thailand, where low unemployment means the most talented workers at present are already taken. Infrastructure build-out across the region will be needed, too. ASEAN countries are facing an increasing infrastructure deficit mainly due to rapid urbanization and population growth. The World Economic Forum, in a 2018 white paper co-authored with A.T. Kearney, urged the ASEAN nations to collaborate on issues like these to achieve full &a;ldquo;readiness&a;rdquo; for production growth.

As a whole, Southeast Asia is not entirely safe from the effects of the U.S.-China trade war. The benefits mentioned above might take a long time to fully come into effect and until then, the region may suffer in the short run from lower trade volumes and a lack of investor confidence. Given both the U.S. and China are major export markets for Southeast Asia, lower trade volumes from China could negatively affect countries that are more reliant on international trade, like Singapore, Malaysia, Thailand and Vietnam.

And ultimately, a classic Catch-22 looms. As Southeast Asian countries become wealthier, wages will rise and their cost advantage will fade. Tomorrow&a;rsquo;s ASEAN firms will have to compete on innovation, quality and ability to serve their home markets. Chinese firms have benefited from the immense size of their domestic market, and now rely on it increasingly.

Keep in mind, though, that the ASEAN region also has a big home card to play. Its combined population of 650 million is larger than either the EU or the U.S.-Mexico-Canada NAFTA trio. With the U.S.-China trade war now having its effects, I&a;rsquo;m even more bullish on&l;span&g;&a;nbsp;&l;/span&g;&l;a href=&q;https://www.slideshare.net/GoldenGateVentures/the-us-china-tradewar-a-boon-for-southeast-asia-131264136&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;Southeast Asia&a;rsquo;s economic potential&l;/a&g;&l;span&g;&a;nbsp;&l;/span&g;than before.&l;/p&g;

Tuesday, February 19, 2019

Hot Medical Stocks To Buy For 2019

tags:FTR,AHPI,GMO,

Healthcare Trust of America Inc (NYSE:HTA) is a real estate investment trust (REIT) that specializes in owning and operating medical office buildings and other healthcare assets in 33 states.

Its focus is on markets with long-term growth and the kind of infrastructure that can support servicing growing patient demand.

In the past year, HTA stock has ended up slightly underwater, losing 3.9% in that time. But its current 4.4% divided has kept it around breakeven, so now is the time to figure out if this is a good time to buy for the long-term, or look for another opportunity elsewhere in the sector.

If you’re looking for a solid long-term healthcare stock that will deliver both growth and a solid dividend, then now is the time to buy HTA stock.

First of all, HTA is REIT, which means you’re investing in an income stock with growth potential, not the other way around. And if that’s the case, then you have to think long-term for the dividend to have a chance to compound.

Hot Medical Stocks To Buy For 2019: Frontier Communications Corporation(FTR)

Advisors' Opinion:
  • [By Daniel B. Kline]

    Frontier Communications (NASDAQ:FTR) CEO Dan McCarthy has never wavered from his steadfast belief that his company will eventually turn itself around. He continually finds positive news to share with investors in the face of ongoing subscriber loss.

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was Frontier Communications Corp. (NASDAQ: FTR) which fell about 8% to $6.70. The stock's 52-week range is $6.08 to $18.60. Volume was 8.1 million compared to the daily average volume of 3.2 million.

  • [By Chris Lange]

    Frontier Communications Corp. (NYSE: FTR) is scheduled to release its most recent quarterly report late Tuesday. The consensus forecast calls for a net loss of $1.04 per share but $2.2 million in revenue. Shares closed most recently at $9.10. The consensus target price is $12.43, and shares have changed hands between $6.08 and $50.85 in the past year.

Hot Medical Stocks To Buy For 2019: Allied Healthcare Products Inc.(AHPI)

Advisors' Opinion:
  • [By Ethan Ryder]

    Allied Healthcare Products (NASDAQ:AHPI) and COLLPLANT HOLDI/S (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.

  • [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Hot Medical Stocks To Buy For 2019: General Moly, Inc(GMO)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on General Moly (GMO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Sunday, February 17, 2019

BitcoinX 24 Hour Trading Volume Hits $43,789.00 (BCX)

BitcoinX (CURRENCY:BCX) traded 0.2% higher against the dollar during the 1-day period ending at 15:00 PM E.T. on February 16th. BitcoinX has a total market capitalization of $0.00 and $43,789.00 worth of BitcoinX was traded on exchanges in the last 24 hours. Over the last week, BitcoinX has traded 21.9% higher against the dollar. One BitcoinX coin can now be purchased for $0.0020 or 0.00000055 BTC on popular exchanges including $10.39, $24.43, $50.98 and $7.50.

Here is how similar cryptocurrencies have performed over the last 24 hours:

Get BitcoinX alerts: Mixin (XIN) traded up 3.5% against the dollar and now trades at $119.90 or 0.03287045 BTC. Sakura Bloom (SKB) traded 5.5% higher against the dollar and now trades at $0.0014 or 0.00000038 BTC. XinFin Network (XDCE) traded up 6.4% against the dollar and now trades at $0.0007 or 0.00000018 BTC. ProCurrency (PROC) traded 15.7% higher against the dollar and now trades at $0.0007 or 0.00000020 BTC. Bitcoin W Spectrum (BWS) traded up 2.6% against the dollar and now trades at $0.0007 or 0.00000019 BTC. USDCoin (USC) traded 0.4% lower against the dollar and now trades at $1.00 or 0.00027535 BTC. LePen (LEPEN) traded down 0.4% against the dollar and now trades at $0.0001 or 0.00000001 BTC. SHACoin (SHA) traded 25% higher against the dollar and now trades at $0.0003 or 0.00000005 BTC.

BitcoinX Profile

BitcoinX (CRYPTO:BCX) is a proof-of-stake (PoS) coin that uses the SHA256 hashing algorithm. It was first traded on January 10th, 2014. BitcoinX’s total supply is 167,361,683,927 coins. The Reddit community for BitcoinX is /r/BCXofficial and the currency’s Github account can be viewed here. BitcoinX’s official Twitter account is @bcx_team and its Facebook page is accessible here. BitcoinX’s official website is bcx.org.

BitcoinX Coin Trading

BitcoinX can be traded on the following cryptocurrency exchanges: $7.50, $51.55, $13.77, $50.98, $10.39, $33.94, $5.60, $20.33, $24.43, $24.68, $18.94 and $32.15. It is usually not currently possible to purchase alternative cryptocurrencies such as BitcoinX directly using U.S. dollars. Investors seeking to trade BitcoinX should first purchase Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Changelly, GDAX or Gemini. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase BitcoinX using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “BCXUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

EmaratCoin (AEC) Reaches 24-Hour Volume of $22.00

EmaratCoin (CURRENCY:AEC) traded up 2.1% against the US dollar during the 1 day period ending at 0:00 AM E.T. on February 16th. During the last week, EmaratCoin has traded 1% higher against the US dollar. EmaratCoin has a total market cap of $0.00 and approximately $22.00 worth of EmaratCoin was traded on exchanges in the last 24 hours. One EmaratCoin coin can now be bought for $0.0311 or 0.00000858 BTC on cryptocurrency exchanges including Trade Satoshi and BiteBTC.

Here’s how related cryptocurrencies have performed during the last 24 hours:

Get EmaratCoin alerts: BOScoin (BOS) traded 5.7% lower against the dollar and now trades at $0.0262 or 0.00000720 BTC. Nasdacoin (NSD) traded 0% higher against the dollar and now trades at $0.64 or 0.00017538 BTC. FLO (FLO) traded up 17.4% against the dollar and now trades at $0.0560 or 0.00001542 BTC. Cashbery Coin (CBC) traded 0.4% lower against the dollar and now trades at $0.0819 or 0.00002254 BTC. Quasarcoin (QAC) traded 12.9% higher against the dollar and now trades at $0.0225 or 0.00000617 BTC. Beetle Coin (BEET) traded 10.5% higher against the dollar and now trades at $0.0085 or 0.00000235 BTC. Apollon (XAP) traded 2.8% higher against the dollar and now trades at $0.0020 or 0.00000054 BTC. Shard (SHARD) traded 15.4% lower against the dollar and now trades at $0.0206 or 0.00000566 BTC. Bitibu Coin (BTB) traded 4% lower against the dollar and now trades at $0.0595 or 0.00001635 BTC. Actinium (ACM) traded down 3% against the dollar and now trades at $0.0292 or 0.00000802 BTC.

EmaratCoin Profile

EmaratCoin (CRYPTO:AEC) is a proof-of-stake (PoS) coin that uses the

Scrypt

hashing algorithm. It was first traded on May 1st, 2016. EmaratCoin’s total supply is 21,566,490 coins. EmaratCoin’s official Twitter account is @EmaratCoin and its Facebook page is accessible here. The official website for EmaratCoin is emaratcoin.com. The official message board for EmaratCoin is emaratcoin.com/#blog.

EmaratCoin Coin Trading

EmaratCoin can be bought or sold on these cryptocurrency exchanges: Trade Satoshi and BiteBTC. It is usually not presently possible to purchase alternative cryptocurrencies such as EmaratCoin directly using US dollars. Investors seeking to trade EmaratCoin should first purchase Ethereum or Bitcoin using an exchange that deals in US dollars such as Coinbase, GDAX or Changelly. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase EmaratCoin using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “AECUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Friday, February 15, 2019

The Post-Earnings Drop of Coca-Cola Stock Is a Buying Opportunity

Coca-Cola (NYSE:KO) stock dropped sharply yesterday after the consumer-staples giant reported fourth-quarter numbers that were largely in-line with expectations. But KO also issued cautious guidance for fiscal 2019 which seemed to incorporate slowing global economic trends and persistent foreign-exchange headwinds, causing KO stock to decline from $50 to $45.

KO stock was trading right near its all-time highs heading into the Q4 print. But its results were pretty good, as its organic sales rose 5% and its operating profits rose 11%.

In that context, the decline of Coca-Cola stock looks like a buying opportunity. Everything is still going well for KO. The company is continuing to pivot from a soda-focused brand to a multi-beverage brand that is much more relevant to today’s health-conscious consumers. That transition is powering consistent, healthy revenue growth.

Meanwhile, KO has exercised disciplined cost control, pushing its margins higher. The result of these trends is healthy, steady revenue and profit growth.

This healthy, steady top-line and bottom-line growth will ultimately power Coca-Cola stock higher. KO stock was trading at a premium valuation heading into the print, supported by unreasonably high expectations. Now expectations are lower, and Coca-Cola stock is cheaper. Thus, now is the right time to buy KO stock.

Q4 Numbers Were Good, But Not Great

Coca-Cola’s Q4 numbers were good. But they weren’t great or anything special. Instead, they were more of the same stable revenue and profit growth that this company has reported over the past several quarters and years.

Thus, in the big picture, Coca-Cola’s top-line growth trajectory has largely stabilized around 4%, excluding acquisitions. The problem was that, when KO stock was around $50, some investors were hoping that 5% and up sales growth was the new norm. That isn’t the case. Fiscal 2018 was just an unusually good year. Next year (and likely for the foreseeable future), organic sales growth  (i.e. excluding the impact of acquisitions) will be in the 3%-5% range.


Compare Brokers

Meanwhile, excluding currency fluctuations, operating income rose 8% in the quarter, and 11% on a trailing-twelve-month basis. That is fairly consistent with what KO has reported over the past several quarters. This low double-digit percentage-operating-profit-growth-trajectory is projected to persist, too, as KO expects its operating profits to rise 10%-11% in 2019.

Overall, KO’s fourth-quarter numbers and its 2019 guidance underscore that Coca-Cola’s growth outlook is stable, but largely below the company’s 2018 results. That disappointed some investors who had bought KO stock last year.

Coca-Cola’s Long-Term Outlook Is Healthy

In the big picture, the long-term fundamentals of Coca-Cola remain healthy. All the post-earnings drop did was make Coca-Cola stock cheaper while showing that KO’s fundamentals remain strong. Consequently, this dip of Coca-Cola stock is a buying opportunity.

Coca-Cola has made a big shift over the past several years, transforming from a soda-focused brand with declining popularity and relevance to a multi-beverage brand with climbing popularity and relevance. As part of this transition, the company has added new iterations like Zero to the core Coca-Cola product lineup, while broadening the product portfolio to include a wide range of teas, coffees, sparkling drinks, and enhanced waters that resonate with today’s health-conscious consumers.

This pivot is working. It’s driving consistent, steady mid-single-digit, organic sales growth. In tandem with management’s cost control measures, the transformation is driving high-single digit percentage to low-double-digit-percentage operating-profit growth.

None of the company’s fundamentals has changed in the wake of its Q4 results. The company’s organic revenues are expected to rise 4% in fiscal 2019, while its operating profits are expected to rise just over 10%.

The only thing that has changed is the valuation of Coca-Cola stock. Heading into the print, KO stock was trading at nearly 23 times analysts’ forward earnings estimate with a sub-3.2% dividend yield. Relative to historical standards, that’s a big P/E multiple and a low yield for KO stock.

Now, though, the valuation of Coca-Cola stock is much more “normal”. Its forward multiple is back around 20, which is roughly in-line with its average valuation over the last five years. The dividend yield has risen to 3.4%, above the average yield of KO stock over the last five years. Meanwhile, KO is still poised to deliver mid-single-digit-organic sales growth and grow its operating profit by about 10%.

As a result, the decline of Coca-Cola stock is a buying opportunity. KO’s fundamentals remain largely unchanged, while KO stock just went from slightly overvalued to slightly undervalued.

The Bottom Line on Coca-Cola Stock

In the big picture, Coca-Cola has a found a winning strategy: Acquiring relevant, popular brands, and distributing them around the globe. As long as this strategy continues to power mid-single-digit organic sales growth and operating-profit growth of about 10%, KO stock should be bought on dips.

As of this writing, Luke Lango was lo

Thursday, February 14, 2019

Implied iShares S&P 500 Value ETF Analyst Target Price: $127

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1126955752&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1126955752/960x0.jpg?fit=scale&q; data-height=&q;720&q; data-width=&q;960&q;&g; Getty

Looking at the underlying holdings of the ETFs in our coverage universe at &l;a href=&q;https://www.etfchannel.com/&q; target=&q;_blank&q;&g;ETF Channel&l;/a&g;, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.&a;nbsp; For the iShares S&a;amp;P 500 Value ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $126.65 per unit.

With IVE trading at a recent price near $111.56 per unit, that means that analysts see 13.53% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IVE&s;s underlying holdings with notable upside to their analyst target prices are AT&a;amp;T, Advance Auto Parts and Chevron. Although T has traded at a recent price of $29.84/share, the average analyst target is 19.36% higher at $35.62/share. Similarly, AAP has 19.30% upside from the recent share price of $166.46 if the average analyst target price of $198.58/share is reached, and analysts on average are expecting CVX to reach a target price of $139.91/share, which is 17.01% above the recent price of $119.57.

Below is a summary table of the current analyst target prices discussed above:

&a;nbsp;

&l;/p&g;&l;div class=&q;table-wrapper&q;&g;&l;table class=&q;hctblstyle&q; border=&q;0&q; cellspacing=&q;0&q; cellpadding=&q;0&q;&g;&l;tbody&g;&l;tr&g;&l;th&g;Name&l;/th&g; &l;th align=&q;center&q;&g;Symbol&l;/th&g; &l;th align=&q;right&q;&g;Recent Price&l;/th&g; &l;th align=&q;right&q;&g;Avg. Analyst 12-Mo. Target&l;/th&g; &l;th align=&q;right&q;&g;% Upside to Target&l;/th&g; &l;/tr&g;&l;tr&g;&l;td&g;&l;b&g;iShares S&a;amp;P 500 Value ETF&l;/b&g;&l;/td&g; &l;td align=&q;center&q;&g;&l;b&g;IVE&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;$111.56&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;$126.65&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;13.53%&l;/b&g;&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;AT&a;amp;T Inc&l;/td&g; &l;td align=&q;center&q;&g;T&l;/td&g; &l;td align=&q;right&q;&g;$29.84&l;/td&g; &l;td align=&q;right&q;&g;$35.62&l;/td&g; &l;td align=&q;right&q;&g;19.36%&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;Advance Auto Parts Inc&l;/td&g; &l;td align=&q;center&q;&g;AAP&l;/td&g; &l;td align=&q;right&q;&g;$166.46&l;/td&g; &l;td align=&q;right&q;&g;$198.58&l;/td&g; &l;td align=&q;right&q;&g;19.30%&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;Chevron Corporation&l;/td&g; &l;td align=&q;center&q;&g;CVX&l;/td&g; &l;td align=&q;right&q;&g;$119.57&l;/td&g; &l;td align=&q;right&q;&g;$139.91&l;/td&g; &l;td align=&q;right&q;&g;17.01%&l;/td&g; &l;/tr&g;&l;/tbody&g;&l;/table&g;&l;/div&g;

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock&s;s trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

&l;a href=&q;http://www.etfchannel.com/slideshows/ten-etfs-with-most-upside/&q; target=&q;_blank&q;&g;Click here to find out 10 ETFs With Most Upside To Analyst Targets &a;raquo;&l;/a&g;

Alembic Pharmaceuticals rises 3% on USFDA approval for Fenofibrate tablets

Share price of Alembic Pharmaceuticals rose 3.5 percent intraday Wednesday after company received USFDA approval for Fenofibrate tablets.

The company's wholly owned step down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets USP, 54 mg and 160 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Tricor Tablets, 54 mg and 160 mg, of AbbVie Inc. (AbbVie).

Fenofibrate tablets are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidaemia and for treatment of adult patients with severe hypertriglyceridemia.

Fenofibrate tablets have an estimated market size of USD 92 million for 12-month ending December 2018, as per IQVIA data.

At 11:02 hrs Alembic Pharmaceuticals was quoting at Rs 563.10, up Rs 17.70, or 3.25 percent on the BSE.

For more market news, click here First Published on Feb 13, 2019 11:11 am

Tuesday, February 12, 2019

Wetherby Asset Management Inc. Sells 609 Shares of Vanguard FTSE Emerging Markets ETF (VWO)

Wetherby Asset Management Inc. lowered its position in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) by 6.6% in the fourth quarter, Holdings Channel reports. The fund owned 8,661 shares of the exchange traded fund’s stock after selling 609 shares during the period. Wetherby Asset Management Inc.’s holdings in Vanguard FTSE Emerging Markets ETF were worth $330,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. bought a new stake in shares of Vanguard FTSE Emerging Markets ETF during the 4th quarter worth approximately $30,000. Mackey Komara & Dankovich LLC bought a new stake in shares of Vanguard FTSE Emerging Markets ETF during the 4th quarter worth approximately $41,000. Versant Capital Management Inc raised its stake in shares of Vanguard FTSE Emerging Markets ETF by 100.5% during the 4th quarter. Versant Capital Management Inc now owns 1,117 shares of the exchange traded fund’s stock worth $42,000 after purchasing an additional 560 shares in the last quarter. Sharkey Howes & Javer raised its stake in shares of Vanguard FTSE Emerging Markets ETF by 160.0% during the 4th quarter. Sharkey Howes & Javer now owns 2,085 shares of the exchange traded fund’s stock worth $79,000 after purchasing an additional 1,283 shares in the last quarter. Finally, Ipswich Investment Management Co. Inc. bought a new stake in shares of Vanguard FTSE Emerging Markets ETF during the 4th quarter worth approximately $87,000.

Get Vanguard FTSE Emerging Markets ETF alerts:

Shares of Vanguard FTSE Emerging Markets ETF stock traded up $0.33 on Tuesday, reaching $41.07. 2,226,473 shares of the company were exchanged, compared to its average volume of 18,269,732. Vanguard FTSE Emerging Markets ETF has a one year low of $36.35 and a one year high of $49.15.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4146010/wetherby-asset-management-inc-sells-609-shares-of-vanguard-ftse-emerging-markets-etf-vwo.html.

Vanguard FTSE Emerging Markets ETF Profile

The Fund seeks to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index, that measures the return of stocks issued by companies located in emerging market countries.

Further Reading: How Do Front-End Loads Impact an Investment?

Want to see what other hedge funds are holding VWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO).

Institutional Ownership by Quarter for Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)

Monday, February 11, 2019

Buy Gail (India); target of Rs 390: ICICI Direct


ICICI Direct's research report on Gail (India)


Gail India reported a good set of Q3FY19 numbers, which came in above our estimates. The profitability of gas transmission, gas trading and LPG segment were above our estimates whereas petchem segment results were below our estimates • EBITDA at Rs 2673.5 crore (up 35.7% YoY) came in above our estimates of Rs 2227.6 crore on account of better gas transmission profits (up 31%), higher margins in natural gas trading (up 2x YoY) and higher realisations in LPG/LLH segment (up 26.7%)• Subsequently, reported PAT at Rs 1681.2 crore (up 33.2% YoY) came in above our estimates of Rs 1377.1 crore.


Outlook


Petroleum and Natural Gas Regulatory Board's (PNGRB) implementation of Gail's proposal for unified tariff plan will provide significant movement in Gail's performance over the long term. In the medium term, tariff revision for HVJ, DVPL pipelines will be positive for earnings. On the operational front, stable gas volumes, further pipeline expansion and growing CGD sector would serve as a key trigger for the stock. However, lower oil prices will impact performance in LPG/LLH and petchem business segments. We value the company using the SOTP methodology, valuing the core business using DCF and assigning a target multiple to the EBITDA of other business segments with BUY recommendation and target price of Rs 390.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Feb 11, 2019 01:29 pm

Sunday, February 10, 2019

Hot Small Cap Stocks To Invest In 2019

tags:ATAI,CNR,MOBI,PQ,ACHN,FCEL, Thesis

As a very small cap Chinese-listed ADR, Yintech (YIN) continues to have little coverage from analysts or otherwise. After a rough 2017 where its rapidly falling comparisons make it a certainty to screen out, the company's transition is not being valued, and a host of strong fundamentals make Yintech an ideal value play.

Poor Screener

There are many reasons that a stock can screen poorly. PE estimates or actuals are way off from reality because of a one-time item, a merger that gives the appearance of growth where there is none, a divestment that makes growth comparisons look awful, and so forth.

Yintech may be one of the worst screens out there at the moment. With revenue falling 10% for the full year and 63.6% in Q4, you would think something is seriously wrong at Yintech. The items that help are the fact that it has a yield and pays a dividend, two curious items for a Chinese stock and a small cap.

I take a look at Yintech's year and discuss its undeniable transition that explains the horrific year-over-year numbers in addition to its rock-bottom valuation.

Hot Small Cap Stocks To Invest In 2019: ATA Inc.(ATAI)

Advisors' Opinion:
  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Hot Small Cap Stocks To Invest In 2019: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:
  • [By Logan Wallace]

    Northwestern Mutual Wealth Management Co. grew its holdings in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 134,917 shares of the transportation company’s stock after acquiring an additional 1,692 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Canadian National Railway were worth $11,030,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) have been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $91.71.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

  • [By Logan Wallace]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) saw some unusual options trading activity on Thursday. Traders acquired 1,956 put options on the company. This is an increase of 1,818% compared to the typical volume of 102 put options.

Hot Small Cap Stocks To Invest In 2019: Sky-mobi Limited(MOBI)

Advisors' Opinion:
  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Hot Small Cap Stocks To Invest In 2019: Petroquest Energy Inc(PQ)

Advisors' Opinion:
  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Hot Small Cap Stocks To Invest In 2019: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Joseph Griffin]

    BidaskClub lowered shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a sell rating to a strong sell rating in a report published on Tuesday morning.

  • [By Stephan Byrd]

    Shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) have earned a consensus rating of “Hold” from the six research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.50.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a strong sell rating to a sell rating in a research report sent to investors on Tuesday morning.

Hot Small Cap Stocks To Invest In 2019: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on FuelCell Energy (FCEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Scott Levine]

    Beyond that, there are numerous stocks, like IAMGOLD (NYSE: IAG) and FuelCell Energy (NASDAQ: FCEL), which I'm certain will not only remain absent from my portfolio but from my watchlist as well. Here's why:

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 17.8% in short interest during the period. Some 6.9 million shares were short as of May 15. The stock closed at $1.88 on Thursday, down about 1.1% for the day, in a 52-week range of $0.93 to $2.49. Shares traded up about 1.4% in the short interest period, and days to cover rose from eight to 14.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

  • [By Ethan Ryder]

    FuelCell Energy (NASDAQ: FCEL) and Integer (NYSE:ITGR) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Friday, February 8, 2019

Adient PLC (ADNT) Q1 2019 Earnings Conference Call Transcript

Logo of jester cap with thought bubble with words 'Fool Transcripts' below it

Image source: The Motley Fool.

Adient PLC (NYSE:ADNT)Q1 2019 Earnings Conference CallFeb. 7, 2019, 8:30 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Welcome to the Adient First Quarter Earnings Call and thank you for standing by. At this time, all participants are in a listen-only mode until the question and answer portion of the conference. If you would like to ask a question today, please press "*1" on your touchtone phone. You'll then be prompted to record your first and last name. This conference is being recorded. If you have any objection, you may disconnect.

Thank you and now I'd like to turn the call over to your host, Mr. Mark Oswald. Thank you, sir. You may begin.

Mark Oswald -- Vice President, Global Investor Relations

Thank you, Marcella. Good morning and thank you for joining us as we review Adient's results for the first quarter of fiscal year 2019. The press release and presentation slides for our call today have been posted to the Investor section of our website at adient.com.

This morning, I'm joined by Doug Del Grosso, Adient's President and Chief Executive Officer, and Jeff Stafeil, our Executive Vice President and Chief Financial Officer. On today's call, Doug will provide an update on the business, followed by Jeff, who will review our first quarter results in more detail. After our prepared remarks, we will open the call to your questions.

Before I turn the call over to Doug and Jeff, there are a few item's I'd like to cover. First, today's conference call will include forward-looking statements. These statements are based on the environment as we see it today and, therefore, involve risks and uncertainties. I would caution you that our actual results could differ materially from these forward-looking statements made on the call. Please refer to Slide 2 of our presentation for our complete Safe Harbor Statement.

In addition to the financial results presented on a GAAP basis, we will be discussing non-GAAP information that we believe is useful in evaluating the company's operating performance. Reconciliations for these non-GAAP measures to the closest GAAP equivalent can be found in the appendix of our full earnings release.

This concludes my comments. I'll now turn the call over to Doug.

Douglas Del Grosso -- President and Chief Executive Officer

Okay. Thanks, Mark, and thanks to our investors and the analysts for joining the call this morning. Let me direct you to Slide 4 for just a few comments on recent developments, including certain key financial metrics which are called out at the top of the slide.

Sales and adjusted EBITDA for the quarter totaled $4.2 billion and $176 million, respectively. Sales were in line with our internal expectations. Operational challenges were a primary contributor to the $90 million year-over-year decline in EBITDA. Adjusted earnings per share fell to $0.31 in the most recent quarter, as a lower level of operating profit dropped right to the bottom line. We ended the quarter with $406 million of cash and net debt totaled approximately $3 billion as of December 31st.

It's important to note the adjusted results exclude certain non-cash charges that we view as one-time in nature or otherwise skewed trends in core operating performance for the company. A list of adjusting items can be found in the appendix.

Outside of the financial results, other recent developments include progress related to our efforts to increase the flexibility of the company's balance sheet, which is important to turnaround. From a customer program perspective, the team continues to secure important new replacement business wins, the most notable being the complete seat business for the next-generation F-150 and BMW 7-Series.

The last point on the slide, Adient's strong market position and performance in China was recently validated externally with the achievement of 21 J.D. Power Initial Quality awards in 2018 across a variety of segments and joint ventures.

Turning to Slide 5, let me spend a few minutes discussing what I've observed during my first 100+ days and, more importantly, what our margin potential could like with the successful execution of the turnaround. The chart on the left illustrates our current and historical EBITDA margin performance. As you can see, we've dropped about 300 basis points to prior performance and operating at a cap of about 400 basis points to others in the Seating business.

As I've mentioned before, there are no structural issues preventing Adient from achieving best-in-class margins. The performance headwinds are rooted in significant operational challenges, primarily launch related, reduced focus on core business, too much emphasis on growth, which also has contributed to undisciplined commercial decisions. When drilling down into the nonperformance, we see roughly 200 basis points of opportunity in our SS&M group and another 150 basis points of opportunity in Seating in America.

Looking forward, we expect to close the margin gap. As we gain clarity on the pace of various operational and commercial actions being executed, we'll be in a better position to share with you our thoughts on how long the gap closure is expected to take. You can expect updates on the subject as we progress through the year.

Let's turn to Slide 6. So, what are the key actions we're taking? On a high level, the major tenets of the turnaround. When thinking about actions, it really translates into what we can do quickly and what will take a longer period of time to complete.

In the first 180 days, the team is really focused on the basics: changing our culture and mindset; fixing operational issues, which include the elimination of operational waste; a continued focus on SG&A savings should also be included in that bucket; commercial discipline, which I view as a high priority and, in fact, I'm personally involved in many of these discussions, which speaks to the importance of resolving them; ensuring our balance sheet has the strength and flexibility to ensure the turnaround; and, longer term, right-sizing our SS&M business. Although this segment is important to our overall business, we need to be far more selective in who we sell our technology to. For too long, this segment has been a cash drain on the company.

Before I turn the call over to Jeff, just a few comments on the performance of our Seating in the Americas and SS&M business. Starting with Seating, our Q1 results were generally in line with our internal expectations of last year to spill over into 2019. As a reminder, a large portion of the North American Seating underperformance is the result of increased volume and complexity of our launch load. These issues have been exacerbated by other factors, such as higher than normal volatility in customer releases, unplanned legacy program extensions, and stretched resources, not to mention macro factors, such as righting the input costs.

That said, we're executing a number of operational and commercial actions to improve our results, including a renewed focus on our core business, incorporating not only better operational performance but also a greater level of focus on commercial decisions; reallocation of resources to problem plants and launches to ensure operational waste is eliminated; and, finally, the elimination of distractions outside the core business. As I mentioned previously, unfortunately, the intense focus on growth within the organization at the time of the spend resulted in distractions away from our core business and stretched our resources. Eliminating these distractions and focusing on the core business is an essential element of our plan going forward. Evidence these actions are taking root are expected to become visible as we progress through the year.

With regard to SS&M, certain operational headwinds that impacted our business in early 2018 are showing significant signs of improvement. These should be viewed as proof points Adient can solve complex issues and turnaround actions are taking root. As 2018 progressed, the combination of successful operational and commercial actions resulted in the program becoming profitable.

Also, the challenges impacting our Rockenhausen, Germany facility that produces recliners were well-documented throughout 2018, specifically, the need for manual lines to meet launch production volumes and premium freight. As Q1 2019 came to a close, the team managed to eliminate the manual line as well as the premium freight. Unfortunately, these positive developments were partially offset by launch-related costs associated with increased common front-seat architecture volume in Europe. Similar to the challenges faced in the plant in Rockenhausen, the team is executing operational actions and working with customers on commercial terms to improve the program profitability.

To sum it up, this slide is a bit of good news and bad news story. 2019 will continue to experience the negative impact of launch-related headwinds in both Seating and SS&M. On the positive side, the message is we can solve these problems, even if they involve commercial issues. But, again, it will take time. Clearly, we have a lot of work in front of us, but rest assured that the team is up for the challenge and I look forward to updating you on our progress as we move through the year.

With that, I'll turn it over to Jeff so he can take us through Adient's financial performance for the quarter and what to expect in the coming months.

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Great. Thanks, Doug. Good morning, everyone. Turning to our financial performance, as Doug stated in his remarks, Adient's first quarter results were in line with internal expectations and consistent to what we discussed at the Deutsche Bank conference in January.

Turning to Slide 9, and in adhering to our typical format, the page is formatted with our reported results on the left and our adjusted results on the right side. We will focus our commentary on the adjusted results. These adjusted numbers exclude various items that we view as either one-time in nature or otherwise skew important trends in underlying performance. The adjusting items are called out in the appendix.

High level, despite a modest decline in sales, adjusted EBITDA for the quarter was $176 million, down $90 million, or 34%, year-on-year, largely explained by a decline in business performance, which I'll cover in a few minutes. Also contributing to the decline was equity income, which was down $26 million in the quarter compared with the same period last year, largely explained by a $14 million decrease within our Interiors Wi-Fi business and $5 million negative FX. Finally, adjusted net income and EPS were down approximately 70% year-over-year at $29 million and $0.31, respectively.

Now, let's break down our first quarter results in more detail, starting with revenue on Slide 10. We reported consolidated sales of $4.15 billion, a decrease of $46 million compared to the same period a year ago. The benefit from increased volume was more than offset by the negative impact of currency movements.

Moving on, with regards to Adient's unconsolidated revenue, our Q1 results held up well relative to overall production in the region. Unconsolidated Seating and SS&M revenue, driven primarily through our strategic JV network in China, was down 7% when adjusting for FX, a good outcome as production was down double digits for the quarter. Strong mix in our customer diversification helped drive Adient's outperformance versus the market. Sales for unconsolidated Interiors, recognized through our 30% ownership stake in Yanfeng Automotive Interiors, was down 1% year-on-year when adjusting for FX. It's important to remember that roughly 50% of the business is conducted outside China.

Moving to Slide 11, we provide a bridge of adjusted EBITDA to show the performance of our segments between periods. The bucket labeled "Corporate" represents central costs that are not allocated back to the operations. These core costs include our executive office, communications, corporate finance, legal, and marketing.

Big picture, adjusted EBITDA was $176 million in the current quarter versus $266 million last year. The corresponding margin related to the $176 million of adjusted EBITDA was 4.2%, down approximately 210 basis points versus Q1 last year. The primary driver of the year-over-year decline is attributed to negative business performance within Seating and, as Doug mentioned, largely operation and launch-related. In addition, Interiors also weighed on our first quarter results, as operational challenges outside of China had a significant impact in the year-over-year results. A $10 million improvement in SS&M and continued cost reductions within corporate were partial offsets.

Similar to the past few quarters, we have included detailed bridges for both Seating and SS&M segments on Slides 12 and 13. Starting with Seating on Slide 12, adjusted EBTIDA decreased to $261 million, down $93 million compared to the same period a year ago. The primary drivers between the periods include approximately $70 million in negative business performance headwinds, many of which were launch-related. I won't go into the specific line items, as we have included them in a callout box.

In addition to the negative business performance, the negative impact of currency movements and increased commodity costs resulted in an approximate $10 million headwind in Q1 this year versus the same period last year. Temporary SG&A benefits recognized last year that did not repeat in Q1 of this year also impacted the Seating segment by about $10 million. And, finally, equity income, excluding the impact of FX, was down $6 million year-over-year. One last point on Seating, our CapEx for the Seating business was approximately $73 million in the quarter.

Turning to Slide 13 and our SS&M segment performance, for the quarter, adjusted EBITDA was negative $72 million, or $10 million better than Q1 2018. The primary drivers between Q1 this year and last year's first quarter include the positive impact of improved business performance, which includes lower launch-related costs and reduced premium freight. Similar to the Seating bridge, a detailed callout box is included on the slide.

Reduced engineering spend and cost control more than offset the temporary SG&A benefits recognized last year that did not repeat in Q1 of this year. The net result was a $1 million improvement in SG&A for the segment. Unfortunately, negative mix, primarily driven by the increased common front seat architecture volume in Europe, combined with the negative impact of FX and lower equity income, partially offset the improved business performance. Regarding SS&M's CapEx for the quarter, the business spent roughly $71 million.

Let me now shift to our cash and capital structure on Slide 14. On the left side of the page, we break down our cash flow. Adjusted free cash flow, defined as operating cash flow less CapEx, was an outflow of $272 million for the quarter. This compares to an outflow of $270 million last year. The negative impact of lower earnings was offset by an increase in customer tooling recoveries, lower restructuring costs, and an absence of a bonus payout. Capital expenditures for the quarter were $144 million compared with $143 million last year. As you can see in the footnote, we continue to break out CapEx by segment.

On the right-hand side of the page, we detail our cash and leverage position. As of December 31, 2018, we ended the quarter with $406 million in cash and cash equivalents. Gross debt and net debt totaled $3.409 billion and $3.3 billion, respectively, as of December 31st. As a result of our cash balance, debt level, and operating performance, Adient's net leverage ratio as of December 31, 2018 was 2.72 times.

Speaking of our net leverage ratio and following up on Doug's earlier comments, post-quarter close, the team amended the company's credit facility. The amendment pivots to a net secured leverage financial covenant, replacing the previous financial covenant which was based on a total net leverage ratio. The maximum net senior secured leverage of 2.5 times steps down to 2.25 times for Q3 and Q4 of our fiscal 2020 and 2.0 times thereafter. Details of the amendment were filed in an 8-K earlier this morning. This amendment should provide stability, flexibility, and strengthens our liquidity position as we explore various options to refinance the company's credit facilities.

One last point on the amendment. At quarter end, the net secure leverage ratio totaled roughly 1.3 times. The calculation is as follows: secured debt per our credit agreement totaled just over $1.5 billion at December 31, 2018, and includes the $1.2 billion Term Loan A, $189 million of our EIB loan, and approximately $142 million of our European factory and facility, subtracting $250 million of cash. Note the agreement caps cash netting at $250 million. The bank-adjusted secured net debt totaled $1.281 billion. The last 12 months of bank-adjusted EBITDA totaled roughly $950 million, resulting in the 1.3 times outcome. The primary difference between Adient's LTM adjusted EBITDA and the bank calculation includes eliminating equity income and adding cash dividends received and eliminating income from minority interests.

Moving on to Slide 15, let me conclude with a few thoughts of what to expect for fiscal 2019. Based on current vehicle production plans and expected movements in foreign exchange, we expect revenue to settle in the $15.5 billion to $16.7 billion range. The primary driver in the forecasted year-over-year decline is FX, which is expected to be an approximately $500 million headwind compared to last year. Softer market conditions in China and a reduction in complete seat business in Europe is also expected to impact revenue, but to a much lesser degree.

With regards to adjusted EBITDA, first half of fiscal '19 is expected to be our low water mark, with improvement expected in the second half. Despite improving results in the back half of the year, full-year adjusted EBITDA is expected to be lower compared to the full-year 2018. As Doug mentioned, the benefit of operational and commercial actions being executed, such as our ability to eliminate the manual lines and premium freights in our recliner business at Rockenhausen, gives us confidence earnings will improve in the second half.

To help dimension our first half's adjusted EBITDA performance, our early read on Q2 has the quarter shaping up to look very similar to the quarter just completed. On a sequential basis, compared to Q1, Seating is expected to decline modestly, while SS&M is expected to show improvement quarter-over-quarter.

As discussed at the investor conferences in Detroit last month, additional updates on the pace of the improvement will be provided through the year as we gain clarity on key variables, such as the pace of the operational and commercial actions, China volumes, and tariff headwinds, to name just a few.

In addition to the operational headwinds, earnings are expected to be impacted by a variety of other factors, including the following: temporary SG&A benefits not repeating in 2019, call it about $20 million per quarter or $80 million for the year; weaker global currencies versus the U.S. dollar, which is expected to be an approximate $50 million year-over-year headwind; elimination of becoming Adient's adjustments, although the costs are expected to be lower versus last year, spending will be absorbed in our operating performance; and, finally, increased Adient aerospace spend versus last year. As a reminder, in 2018, the JV was not formed yet, so we only had about $15 million of net expense while Boeing funded the other $15 million. This year, we will spend the same, roughly $30 million, and Boeing will continue to reimburse for their share. However, as we are consolidating this business, we will still have the entire $30 million in reported results.

Moving on, Adient's effective tax rate is expected to be in the high-teens to low 20% range. For modeling purposes, call it 20%. The higher effective rate versus last year is primarily due to the establishment of the valuation allowance in certain jurisdictions where losses were previously benefited. If you recall, last year's fourth quarter results were significantly impacted by the establishment of the valuation allowances.

Important to note, the higher effective tax rate does not impact our cash taxes. For fiscal 2019, we expect our cash taxes to decline year-over-year. One additional point on cash taxes -- more than 50% of our cash tax payments were related to consolidated JVs and withholding taxes on dividends from our JVs.

On a side note, I'll mention the asset impairments called out in last year's Q4 will have an impact on 2019 as it relates to depreciation. Because of the asset writedowns, we expect deprecation for the year to total about $300 million, significantly lower compared with last year.

And one last item for your modeling, we expect capital expenditures to be in the $550 million to $575 million range for the year. Although we see opportunity to reduce capital expenditures in the out years, driven by a smaller SS&M business, the current year expenditures are supporting current year launch plans.

With that, let's move on to the question-and-answer portion of the call. Operator, can we have our first question, please?

Questions and Answers:

Operator

Certainly, sir. Thank you. If you would like to ask a question, please press "*1" on your touchtone phone. You'll be prompted to record your first and last name and called on at your turn. One moment.

Our first question comes from Colin Langan at UBS.

Colin Langan -- UBS -- Analyst

Great. Thanks for taking my question. Any color -- you highlighted the debt refinancing. Are you done there on the debt side or is there more actions to come that you were talking about at Detroit? And any thoughts, there's a lot of chatter about an equity raise? I mean, is that something that's still on the table?

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Thanks, Colin. We thought it was prudent to do the amendment. The debt markets are certainly pretty choppy. It gives us opportunity to refinance. That is still our goal to refinance the credit facilities, Colin. The primary reason is, while the amendment really gets us through the maturity of our term loan, that is middle of 2021. So, just from a maturity extension standpoint, we would certainly need to go out to the market sometime soon. So, this gives us flexibility on timing, gives us quite a bit more flexibility and room, but the intention here would be to still go out and look for refinancing.

As it relates to capital structure comments, I'd comment that, obviously, our capital structure was sized for a different level of earnings. As we execute on the turnaround, we should be able to de-lever through improving our operations and our earning. But we are, obviously, focused on making sure the company has flexibility, liquidity, etc. to execute the turnaround plans. The primary focus of us, at this point, is the refinancing. And the amendment just gives us a little bit more time.

As it relates to equity, that's not our first focus. Our first focus is definitely on the debt markets but I'd just say that we're obviously looking at all paths and opportunities, given sort of the uncertainties in the macro environments and some of the specifics of our internal turnaround.

Colin Langan -- UBS -- Analyst

Got it. And any color, you've talked in the past about mispriced business. Any update on how big of a revenue base that is and how those talks started and is there any progress there?

Douglas Del Grosso -- President and Chief Executive Officer

So, I'm sorry, Colin. Which business segment were you referring to?

Colin Langan -- UBS -- Analyst

I think in the past, you've discussed how some of the contracts were mispriced.

Douglas Del Grosso -- President and Chief Executive Officer

Oh, mispriced.

Colin Langan -- UBS -- Analyst

At customers. And I don't think there's ever been a framing of was this $1 billion of business that needs to get rediscussed. Or refer to the sizing of it and how are those initial discussions going if they started?

Douglas Del Grosso -- President and Chief Executive Officer

So, most of the discussion has been focused on SS&M, obviously, and to a certain degree, our Seating business in North America. I'll hold back quantifying it, specifically. I think what we've said in the past, it's a handful of customers on a handful of programs. So, it's not widespread throughout the entire business, including SS&M. We're in the midst of those talks right now. We've established what we think our -- you know, a fair resolution.

But until we really get clarity through our customer where we think we'll end up, we're really not prepared to get into a tremendous amount of detail on those specific discussions. As you can imagine, it's pretty confidential and I don't know if it's appropriate for us to be publicly quantifying that and mentioning it that way. And we'd say we've had some initial success. I think some of that has been reflected in Q1. I think some of that is also reflected in the performance improvement we've seen on a year-over-year basis with SS&M. But, really, to get where we want to go, we've got some more work. And I would expect later in the year, we'll have a lot better visibility on that.

Mark Oswald -- Vice President, Global Investor Relations

Operator, can we have our next question?

Operator

Certainly, sir. Thank you. Emmanuel Rosner, your line is open.

Emmanuel Rosner -- Deutsche Bank -- Analyst

Hi. Good morning, everybody.

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Good morning.

Douglas Del Grosso -- President and Chief Executive Officer

Hello.

Emmanuel Rosner -- Deutsche Bank -- Analyst

Hi. So, my first question is I'm curious to understand a little bit better what underpins your view of a better second half EBITDA than the first half. So, I don't know what's the best way to approach it. Maybe some of the actions that you were sort of highlighting on that Slide 6 for the first 180+ days. What is it that you see, specifically, that would improve and also bear results as soon as in the second half? Because, arguable, in that fiscal first quarter, there was little evidence of improvement yet.

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Sure. At the analyst conference in January, we attempted to shed a little bit of light on that and we broke it down by business segment. So, for each business segment, we identified what underperforming plants we were focused on, what commercial activity we had, from an uplift standpoint, where we were on material economics, what restructuring projects we had in place, what we were doing from just an overall launch standpoint. And so for SS&M, North American Seating, and Europe and Asia, we mapped that out and we laid it out against a timeline that extended out a couple years.

I think the way to think of it is, with each one of those subgroups, there's specific actions that we're executing right now. That will take place for the balance of this year. And as we get to the end of the year, we'll start to see the benefit of that and that translates into improved performance as we move into the next fiscal year.

Emmanuel Rosner -- Deutsche Bank -- Analyst

Appreciate this but, I guess, maybe if you just want to restate that from a high-level point of view for us. I'm just -- I don't have a good appreciation of, on a plant-by-plant level, the magnitude of what the promise and what the drag is, specifically, on earnings. And so I'm just curious, when you sort of look at the second half of this fiscal year, how would you sort of rank the biggest drivers of improvement? Is it the commercial discussions you're having with customers right now? Is it the launch problems that will go away or that have already gone away? Sequentially, how would you rank the biggest drivers of improvement?

Douglas Del Grosso -- President and Chief Executive Officer

So, I think, consistent with comments we've made in the past, I think we've said they're roughly split operationally and commercially. I would say the operational issues are easier for us to predict because they're very much dependent on actions that we can execute ourselves. The commercial issues, I think, are a little bit harder to anticipate until we get further into the negotiations.

Emmanuel Rosner -- Deutsche Bank -- Analyst

Okay. And then just, finally, in terms of what are the factors of uncertainty going into the second half? I think we don't have to sort of focus on the macro. I think a lot of us understand what the macro volatility is. But, specifically within your guidance and your view, what are you assuming to get to a better second half? And then what are sort of still the factors of uncertainty that prevent you from giving more specific guidance?

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

So, without getting too specific, you said ignoring macro, I think macro has to be included in the discussion. China, certainly, an area that we're anticipating much improved performance in the second half of the year in the market but that's not completely crystallized how that develops. We're still awaiting action out of the central government to stimulate the market there. You have macro issues like Brexit. We've got a number of our customers in the UK or in Europe, in general, that could be impacted by that. We anticipated some activity there but it's not, again, crystal clear how that plays out. Tariffs are looming and could also have an impact on that. We've had a lot of commercial discussions with our customers. We've made those -- the negotiations have been inclusive of tariffs so we think we're somewhat protected/hedged on that but it's not completely clear how that plays out. We've seen some improvements in the material economics to a certain degree, particularly in steel, but, again, you can call those macro factors but I think those are the things that are certainly out of our control but we're trying to comprehend as we talk to our customers on the impact to our business.

Emmanuel Rosner -- Deutsche Bank -- Analyst

Great. Thank you.

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

You're welcome.

Operator

Our next question comes from Brian Johnson of Barclays. Your line is open, sir.

Brian Johnson -- Barclays -- Analyst

Yes. Hi, good morning. This is Stephen on the line for Brian. Just to follow on to Colin's and, to a lesser extent, Emmanuel's question around some of these enterprise commercial contracts. If you look at the backlog that was last disclosed, we see a decent step-up in the backlog from 2019 of about $450 million on the consolidated Seating front to about $1 billion in 2020. So, I understand that might have changed since the last backlog update but I'm just wondering have you been able to go through the 2020 backlog, in terms of figuring out what percentage of that is potentially underpriced? As was seen here in 2018 and the first half of 2019, to what extent could some of that step-up in the backlog in 2020 be underpriced and at what point do you expect to gain greater visibility into some of those contracts and pricing?

Douglas Del Grosso -- President and Chief Executive Officer

Sure. So, we're spending a tremendous amount of time in that particular area. As we talk about things, kind of some back to basics and commercial discipline, that's kind of coded for ensuring that everything that we bring on that is not yet launched is going to earn a respectable return on capital. And where it's not, then we have to have some serious discussions about how we proceed.

I'd remind you, the way I'd look at the Seating business, and I think it's true for a number of engineered products in the supply base, during the course of the development from award to start of production, the scope of the product changes. Specifications, applications to meet consumer requirements all change. And it's through that process that you have to take action and ensure that your product is properly priced. I would say if there's a flaw that we've had in the way we've operated historically, we've been reluctant to press those issues when they needed to be pressed with our customers and we waited until they accumulated and they were pretty sizable and difficult for our customer to handle.

So, we've got back to a much more disciplined approach in the way we program manage and the way we commercially discuss issues through the development so we avoid some of the problems we're dealing with right now. So, I'm feeling far more confident that we're much aligned with our expectations on this backlog of business that's coming on to what's kind of unfolded over the last two years here. And we're not going to be creating a crisis with our customers. We're going to get back to kind of a normal way of managing our business and the returns on that business is going to be in line with our prior performance and closer to the gap performance we've talked about.

And that's why we indicate, particularly on the metals and mechanisms business, that we're indifferent, if you will -- we're OK to scale that business down because we want to ensure what we bring on has got the proper return. So, where we don't see that happening, where there's customers where, historically, we haven't been able to execute reasonable levels of profitability, we're just not pursuing that business and we're concentrating our efforts where, historically, we've demonstrated much better performance or we think we understand the expectation of the customer and we're pricing it at an appropriate level.

Brian Johnson -- Barclays -- Analyst

Okay. And then a somewhat related question, just around the current pricing environment and margins for business, call it business that will be launching in the 2021-2022 and beyond timeframe. I understand you think there's no real structural reason why Adient's margin shouldn't be comparable to peers but just trying to think through, as you go out and price new business with OEMs, is Adient potentially at a disadvantaged position, just given current operational issues and having to renegotiate current contracts or contracts that are about to launch? And then, also, in light of Adient's leverage relative to competition, e.g., you might have to kind of take contracts that are slightly lower margin relative to competition to gain back some business or gain back the trust of customers.

Douglas Del Grosso -- President and Chief Executive Officer

Yeah. We tried to hit on that point in our formal comments at the beginning of the call. Jeff pointed to a couple of awards, namely the F-150 and BMW 7-Series that we successfully won that business in a competitive environment. We're very confident in the returns at the level we priced that business, although we have to go through a two-year development so there's still a lot of work to be done. But I think we have a much better handle on how we progress through that development cycle. We weren't able to be specific but there was a Japanese customer who awarded us a major mid-size SUV program that we're pretty excited about.

So, it's a balancing act. We understand that. I understand that. But we have to have fairly priced products, period. And we're pretty determined to get there on our existing book of business. My experience has been, if you're prepared, if you're having intelligent discussions with your customer, you can navigate through this without having a significant impact or any impact, if you will, on your backlog. So, that's not a huge concern on my part. I think we can navigate those waters effectively.

The comments about structural aspects of our business and not seeing competitive gaps. I think that's just more a function, if I look at our manufacturing footprint, if I look at the fact that we have locations in the proper regions of the world, we've got great scale in those regions, be it China, Mexico, Eastern Europe, so we're very capable of operating in those regions. I look at the competitiveness even in the SS&M, on our mechanisms business, and I look at the performance aspects, whether it's strength, weight, cost on those components, and all of the benchmark data that I've seen since I've been here is very favorable.

I just keeping going back, a lot of our problem right now is execution. So, it's clearing distractions away from the team, getting us focused on being very passionate about execution in every form of it, and I think if we do that, again, we can get back to a level of performance that we enjoyed just a few years ago. And I think we can outperform that but it's going to take some time to get it back on track.

Brian Johnson -- Barclays -- Analyst

Okay. Thanks for taking my questions.

Operator

Thank you. Our next question comes from John Murphy from Bank of America. Thank you, sir.

John Murphy -- Bank of America Merrill Lynch -- Analyst

Good morning, guys, and good to hear from you, Doug. I guess a first question. When you think about Seating and SS&M, what do you think are the adequate margins that will generate adequate returns? I mean, on the Seating side, mine has been 5% to 6% operating margins return mid-teens invested capital. I'm just curious, as you're looking at this, Doug, and going through it, where you think the adequate level is? I mean, we could talk about peer levels and stuff like that but, I mean, where do you think the adequate level is?

Douglas Del Grosso -- President and Chief Executive Officer

Yeah, I don't think we've formally come out with a number. First of all, it's nice to hear from you, too, John. Thanks. You know it's a capital intense business. So, we should be demanding a higher level of return on the invested capital. Without getting too specific, on an EBITDA level, we'd like to see that business get back to something in the double digit range but we're a long way away from that. But I would categorize that with a lot of proprietary technology, capital intense business, if you want to stay in that game, then that's kind of the level of returns you should have. And if you can't see a way to get there, then we probably want to minimize that as a segment of our business. But, right now, I don't see a reason why we shouldn't be holding that up as an objective for ourselves.

John Murphy -- Bank of America Merrill Lynch -- Analyst

Okay. And then maybe sort of a second question that's sort of a follow-on and related. When you're saying there's no reason that you couldn't get to peer margins, we are looking at peer margins that, on a fully loaded basis, are in the 7% EBIT or operating range, plus or minus, depending on the quarter and the year. Do you think that as you get more competitive in the market and the business gets healthy, that's the level that their margins should be at? Or has there been this run, and I think you're probably understanding who I'm getting at, where, as Adient's been a little bit down and out as part of JCI and now, sort of more recently, with some missteps, that they may have sort made hay and maybe over-earned a little bit for some period of time? Or is that too extreme a read across?

Douglas Del Grosso -- President and Chief Executive Officer

To me, that's a little bit too extreme. I think it's about execution. If you just look at what's been happening to us, I mean, the launches have been brutally painful. They've extended far beyond the normal launch window of 90 days. We're carrying a tremendous amount of labor and freight penalties associated with that poor performance. There's an element, as I said, of commercial discipline, not pricing the product when changes occur. And we're having to go back now and have those discussions post-launch. That's not the time to do it.

From my observations, I would say the other guys have just been executing really well. I don't know that it's necessarily been a result of any failures on our part. I think they've just done well, making sure that they're pricing products right, they're pricing it through the development cycle, and they're very focused on launch execution. That's my visibility I can say on their performance.

John Murphy -- Bank of America Merrill Lynch -- Analyst

Okay. That's helpful. And then just lastly -- and I apologize, I got on the call late. I mean, it sounds like you got reaffirmation from Ford and BMW on the F-150 and the 7-Series and you just mentioned, presumably, one of the J3, you've got a program with on a crossover. So, it sounds like the Seating business is going well. I mean, you kind of alluded to SS&M potentially shrinking strategically because it might make sense. But on the Seating side, is there any rational reason to think about shrinking the business over time as you go out there and bid on new programs? Or is that really just something that we should think about as isolated to SS&M and then Seating, as you get your ducks in a row here, get everything set, that there's no rational reason to be really thinking about shrinking the Seating business over time? You would want to grow. Is that kind of a fair statement?

Douglas Del Grosso -- President and Chief Executive Officer

It's more of an SS&M statement. That's why we specifically point to it that way. I think a lot of that has to do with the capital nature of the business and why we need to be far more selective. I would say commercial discipline applies to all elements of our business. So, the Seating business is not immune. But I think, on the Seating side, we've done a pretty effective job, with the exception of launch management, and that's hurt us. If you go back and you look at some of our other presentations, typically, in the Americas, there's been a real uptick in launch activity that we haven't managed all that well. But I wouldn't say the scaling down of the business applies on the Seating side right now.

John Murphy -- Bank of America Merrill Lynch -- Analyst

Okay. Very helpful. Thank you, guys.

Douglas Del Grosso -- President and Chief Executive Officer

Thanks, John.

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Thanks, John.

Operator

Next we take a question from Joe Spak of RBC.

Joseph Spak -- RBC Capital Markets -- Analyst

Thanks. Good morning. I wanted to maybe follow on a little bit about the right-sizing SS&M. And you had this comment about cash flow-neutral for that business by '21. And since it sounds like you're shrinking it, obviously the CapEx comes down. But does that also imply -- that statement, you could sort of read into it that maybe you get back to a positive EBITDA before that timeframe. Is that how you're thinking about the cadence of that and the cash flow neutrality is maybe a little bit later?

Douglas Del Grosso -- President and Chief Executive Officer

I think that's a way you could look at it. As Jeff mentioned, we're still spending a fair amount of capital on that business right now because those are programs we're committed to launch. We're contractually obligated to launch. So, I would think about it, from a cycle standpoint with SS&M, that in '18, and to a certain degree in '19, we suffered through a lot of launch-related, commercial-related issues that we're trying to unwind and address. That requires a tremendous amount of resources as we do that. As we look to scale down the business, that means our revenues will come down. You should think about that in a two-year timeframe. And that began about a year ago so we're a year out.

As we fix issues, we get our commercial issues behind us, launch activity comes down, you don't have the capital expense, you don't have the launch-related expense, even if the launch goes well, and you can take a lot of those resources that have historically been running around trying to fix problems and you can point them inward and drive a lot more productivity into the business. Which, quite frankly, we haven't done and you could argue that's part of the reason we're struggling in the Seating business in North America is we diluted our resources to solve launch-related issues and we haven't been taking steps to drive productivity, activities like BABE and improve margins. So, it's kind of -- you look at SS&M as we, at a macro level, said this is kind of a 2-3 year process to get the business right, in the scope of scaling it down as well. I don't know if that's helpful or it necessarily answers your question.

Joseph Spak -- RBC Capital Markets -- Analyst

I guess the other -- maybe you could just shed some light, because it's a little bit unclear, to me, anyway, in terms of the new recliner series and I think also the common architecture that you talked about in Europe, it sounds like that has weighed on profits. It probably didn't come on as profitable as you imagined. And it seems like what you're saying is you actually need -- there's definitely some improvements you can do internally but you also sort of need the volumes higher. So, I mean, I guess I don't understand exactly what the turning point is for those businesses from a volume perspective. And how should we think about a wide time range for when you can sort of turn those new products, I guess, around?

Douglas Del Grosso -- President and Chief Executive Officer

They're kind of two different product lines, quite frankly. The recliners are part of our mechanisms business. That's truly proprietary technology. We have a good understanding of what the market price is. And the problems we had, specifically at Rockenhausen, were all related to our launch of that new series. And I think we've talked in past presentations that '18 was the year we launched and converted from this 2000 Series to the 3000 Series of our mechanisms business. That was an expensive undertaking, a lot of capital. Some of that capital is still being employed this year and a lot of launch expense. In Rockenhausen, we talked about the manual lines that we needed to put in place to address our backlog and that the backlog led to a lot of premium freight. And we've slowly worked through those issues.

The common architecture is a slightly different problem, in that it's not as much proprietary technology, it's a joint development that we've had with a couple of customers that was originally intended to be a common design that was going to be deployed across a number of different platforms. What's happened through the development is it's proliferated into many different designs. That's made it more expensive from an investment standpoint. It's made it more difficult to launch. We certainly had our share of issues there. And that scope change has created a big commercial discussion with our customers. That activity is impacting us in the first half of '19.

So, as we solve our problem on the recliner side, we are now grappling with a new issue on this common architecture and that's why you're not seeing a significant improvement on a year-over-year basis. It's offset a lot of the improvement we achieved on the metal and mechanisms side. So, we think we're out of the woods on the mechanisms side. We still have work to do but we're in a far better position than we were a year ago. It's now really getting our arms around this common architecture, which is a huge program that we're in the final stages of launching and addressing the issues I've pointed out.

Joseph Spak -- RBC Capital Markets -- Analyst

So, it's not necessarily a volume issue on the common architecture. It's a commercial issue and getting the pricing for the different variants that evolved that you didn't initially expect.

Douglas Del Grosso -- President and Chief Executive Officer

It's volume from the perspective that we're launching and volume's increasing as we go through the launch but it's not a volume issue in the traditional definition.

Joseph Spak -- RBC Capital Markets -- Analyst

Okay. Thank you.

Mark Oswald -- Vice President, Global Investor Relations

Thanks, Joe. Marcella, it looks like we have time for one last question.

Operator

Thank you. That will come from Armintas Sinkevicius, Morgan Stanley. Go ahead, sir, with your question.

Armintas Sinkevicius -- Morgan Stanley -- Analyst

Great. Thank you for taking the question and congratulations on the wins with the Ford F-150 and the BMW 7-Series. Just curious, as you think about the capital structure of this business and the refinancing activity here, maybe it's early, but has leverage or balance sheet even remotely come up in conversations with the OEMs? And at what level do you think that that would become a question or a conversation that you would have as it relates to new business?

Douglas Del Grosso -- President and Chief Executive Officer

That issue has not come up with our customers. Certainly, we've had discussions with our customers around our declining share price and our financial performance. We've been pretty transparent with them. Quite frankly, a lot of the materials you see in our earnings deck are information we share with them, not just the financial side but what our anticipated road to recovery is. Those discussions have included me. I know Jeff has had discussions with them just to give them the clarity that they'd like to have on us financially. But that's not been a barrier for us to win business.

Armintas Sinkevicius -- Morgan Stanley -- Analyst

Okay. And maybe the flip side of that question is what are customers focused on, given sort of the recent launch issues, and how are you providing them with comfort and anything else that they've been asking about?

Douglas Del Grosso -- President and Chief Executive Officer

Our customers are really focused on the same thing they're always focused on. They want us to be cost-competitive. They want us to execute. They want us to focus on quality and delivery. They want us to have candid conversations with them. They want a level of transparency on what's happening in our business. They want to understand what our strategy is. We're a pretty valuable asset to our customers. We do a lot of things extremely well. We, obviously, have stumbled most recently but when you look at our technology, when you look at our capability, when you look at the way we've got diversification within region and within customer and not overconcentration, our fundamentals stand up against anyone, certainly, in the seating business and, arguably, in the supply business. So, we have a lot to offer them. We just have to get better at executing, get back to what, historically, we, quite frankly, had done extremely well.

And, again, maybe this is an oversimplification but I don't think so -- it's taking distraction out of the way for the team, allowing them to focus and deploy where we need to operationally focus, and not being overly eager to win every business to necessarily promote backlog growth but to have good, strong commercial discipline and have candid, intelligent discussions with our customers, which we do all the time. And, to varying degrees, it seems to make sense to them. But our top priority, and this is what I communicate to our customers all the time, is we have to get back to a level of profitability that's right for this business. This is not sustainable. And we'll correct our problems but we'll engage with you where we think there's issues on both sides.

Mark Oswald -- Vice President, Global Investor Relations

Unfortunately, we're out of time so that will conclude the call this morning. Again, thank you very much for participating. If you have any follow-up questions, please don't hesitate to call.

Douglas Del Grosso -- President and Chief Executive Officer

Thank you.

Operator

This does conclude today's conference. Thank you all for your participation and you may disconnect your lines at this time.

Duration: 63 minutes

Call participants:

Mark Oswald -- Vice President, Global Investor Relations

Douglas Del Grosso -- President and Chief Executive Officer

Jeffrey Stafeil -- Executive Vice President and Chief Financial Officer

Colin Langan -- UBS -- Analyst

Emmanuel Rosner -- Deutsche Bank -- Analyst

Brian Johnson -- Barclays -- Analyst

John Murphy -- Bank of America Merrill Lynch -- Analyst

Joseph Spak -- RBC Capital Markets -- Analyst

Armintas Sinkevicius -- Morgan Stanley -- Analyst

More ADNT analysis

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

10 stocks we like better than AdientWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Adient wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of January 31, 2019